ELZA and the Second Global Consensus on Keratoconus and Ectatic Diseases
The Second Global Consensus on Keratoconus and Ectatic Diseases was published today, and ELZA played a key role in its development.
Mark Hillen
June 2, 2026
The Second Global Consensus on Keratoconus and Ectatic Diseases was published today, and ELZA played a key role in its development.
Can sunlight and riboflavin (vitamin B2) treat keratoconus? New publication explains why current evidence does not support it.
“The eye, once thought sterile and immunoprivileged, is entangled in systemic crosstalk between microbial tenants and ocular health.”
Our latest review on corneal cross-linking (CXL), published in Progress in Retinal and Eye Research, explores its evolution, advanced protocols like ELZA-PACE, and clinical applications.
